Article
Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.
Biochemical and biophysical research communications - 21 Apr 2000
Almeida M R, Alves I L, Terazaki H, Ando Y, Saraiva M J
Abstract excerpt
Recently, a new nonpathogenic transthyretin (TTR) variant-TTR R104H (TTR H104)-has been described in heterozygotic and compound heterozygotic individuals from a Japanese family with familial amyloidotic polyneuropathy (FAP). The compound heterozygotic individual, a carrier of TTR V30M (TTR M30) and TTR R104H (TTR M30/H104) presented a very mild form of FAP with slow progression of the disease. TTR and retinol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
